Are you serious? With all due respect you need to do more research before you invest. BIT225 is potentially part 1 of a 2 part cure for HIV. That market is HUGE, in addition, it accelerates immune system response, so could have use cases beyond what has been mentioned here. BIT225 is one of hundreds of compounds which Biotron have developed.
Gilead, J&J, etc. make $Bs in annual revenue from existing antiviral meds. What do you think they’d pay for a company that threatens their business model?
$10 Billion Deal, page-6209
-
- There are more pages in this discussion • 7,059 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
